City

Stanford (1)

Condition

Low Grade B Cell Lymphoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Celgene (1)

Collaborator

Stanford University (1)

Intervention

vtx-2337 plus radiotherapy (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

low grade b cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Low Grade B Cell Lymphoma Trial in Stanford (VTX-2337 plus radiotherapy)

Terminated

Low Grade B Cell Lymphoma

VTX-2337 plus radiotherapy

Stanford, California

Stanford Cancer Center

Sep 23, 2019